New Launch7 Jan 2026, 04:06 pm
Medicamen Biotech Receives EU Approval for Paracetamol Registration with XGX Pharma in Denmark
AI Summary
Medicamen Biotech Ltd. has announced that it has received EU approval for the product registration of Paracetamol from the Danish Medicine Authority. This approval has been granted in collaboration with XGX Pharma in Denmark. This is a significant achievement for the company, as it continues to expand its reach and product portfolio in the European market.
Key Highlights
- Medicamen Biotech has received EU approval for Paracetamol product registration from the Danish Medicine Authority.
- The approval is a result of collaboration with XGX Pharma in Denmark.
- This is a significant step for the company in expanding its reach and product portfolio in the European market.
- The company is committed to continuing its efforts in the development and registration of high-quality pharmaceutical products.